Johnson & Johnson antiviral pill for dengue shows early efficacy

Off Biotech, biotechnology, CRISPR, drug development, FDA, global health, Health, health care, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today, we see data from ESMO showing that Roche’s alectinib works well in some early stage lung cancers, see our first preventative dengue pill, and more.

Read the rest…

Read Original Article: Johnson & Johnson antiviral pill for dengue shows early efficacy »

About The Author